FilingReader Intelligence
China Resources Pharma proposes 500m yuan biotech fund
August 12, 2025 at 03:11 PM UTC•By FilingReader AI
China Resources Pharmaceutical Group is discussing formation of a 500 million yuan fund targeting investments in synthetic biology, innovative drugs, and biotechnology.
The group's proposed capital commitment will not exceed 123 million yuan, representing 24.6% of the total. Shenzhen CR Capital is expected to manage the eight-year fund.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:3320•Hong Kong Exchange
News Alerts
Get instant email alerts when China Resources Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime